Compare with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

REPCO HOME vs INDOCO REMEDIES - Comparison Results

REPCO HOME     Change

Repco Home Finance Ltd or RHFL is a professionally managed housing finance company headquartered in Chennai, Tamil Nadu. Incorporated in April 2000 as a wholly owned subsidiary of the Repatriates Co-operative Finance and Development Bank Limited (Rep... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    REPCO HOME INDOCO REMEDIES REPCO HOME/
INDOCO REMEDIES
 
P/E (TTM) x 3.5 77.9 4.5% View Chart
P/BV x 0.6 2.8 22.1% View Chart
Dividend Yield % 1.6 0.5 337.3%  

Financials

 REPCO HOME   INDOCO REMEDIES
EQUITY SHARE DATA
    REPCO HOME
Mar-18
INDOCO REMEDIES
Mar-18
REPCO HOME/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs923317 290.8%   
Low Rs515178 289.2%   
Sales per share (Unadj.) Rs176.7113.1 156.3%  
Earnings per share (Unadj.) Rs32.94.5 737.6%  
Cash flow per share (Unadj.) Rs33.411.8 283.1%  
Dividends per share (Unadj.) Rs2.201.00 220.0%  
Dividend yield (eoy) %0.30.4 75.8%  
Book value per share (Unadj.) Rs215.473.2 294.1%  
Shares outstanding (eoy) m62.5692.15 67.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.2 185.7%   
Avg P/E ratio x21.855.5 39.3%  
P/CF ratio (eoy) x21.521.0 102.5%  
Price / Book Value ratio x3.33.4 98.7%  
Dividend payout %6.722.4 29.8%   
Avg Mkt Cap Rs m44,98122,830 197.0%   
No. of employees `0000.85.5 14.4%   
Total wages/salary Rs m4882,209 22.1%   
Avg. sales/employee Rs Th14,081.91,910.1 737.2%   
Avg. wages/employee Rs Th621.3405.0 153.4%   
Avg. net profit/employee Rs Th2,625.775.5 3,479.9%   
INCOME DATA
Net Sales Rs m11,05410,419 106.1%  
Other income Rs m2347 49.0%   
Total revenues Rs m11,07710,466 105.8%   
Gross profit Rs m9,6341,349 714.0%  
Depreciation Rs m31677 4.6%   
Interest Rs m6,484235 2,757.8%   
Profit before tax Rs m3,143484 649.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,08272 1,494.1%   
Profit after tax Rs m2,061412 500.8%  
Gross profit margin %87.212.9 673.0%  
Effective tax rate %34.415.0 230.1%   
Net profit margin %18.64.0 472.0%  
BALANCE SHEET DATA
Current assets Rs m7,1545,373 133.2%   
Current liabilities Rs m32,9504,157 792.7%   
Net working cap to sales %-233.411.7 -1,999.5%  
Current ratio x0.21.3 16.8%  
Inventory Days Days068 0.0%  
Debtors Days Days073 0.0%  
Net fixed assets Rs m1356,244 2.2%   
Share capital Rs m626184 339.4%   
"Free" reserves Rs m12,8506,566 195.7%   
Net worth Rs m13,4766,750 199.6%   
Long term debt Rs m50,9011,233 4,128.9%   
Total assets Rs m99,93912,363 808.4%  
Interest coverage x1.53.1 48.5%   
Debt to equity ratio x3.80.2 2,068.1%  
Sales to assets ratio x0.10.8 13.1%   
Return on assets %8.55.2 163.4%  
Return on equity %15.36.1 250.8%  
Return on capital %15.09.0 166.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m281,143 2.5%   
Net fx Rs m-282,619 -1.1%   
CASH FLOW
From Operations Rs m-5,5711,227 -453.9%  
From Investments Rs m4-1,360 -0.3%  
From Financial Activity Rs m5,615-388 -1,448.4%  
Net Cashflow Rs m49-521 -9.4%  

Share Holding

Indian Promoters % 37.3 59.2 63.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 12.5 132.0%  
FIIs % 30.1 6.0 501.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.2 22.4 72.3%  
Shareholders   12,020 12,805 93.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare REPCO HOME With:   KITEX GARMENTS  IL&FS INV. MANAGERS  CENTURY PLYBOARDS  EDELWEISS FINANCIAL  WONDERLA HOLIDAYS  



Today's Market

Sensex Trades on a Volatile Note; HCL Technologies & Bajaj Finance Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note, tracking mixed global cues as coronavirus cases continue to surge across the world.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

REPCO HOME SHARE PRICE


Jul 8, 2020 12:05 PM

TRACK REPCO HOME

  • Track your investment in REPCO HOME with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

REPCO HOME - COX & KINGS COMPARISON

COMPARE REPCO HOME WITH

MARKET STATS